AstraZeneca’s Soriot Dismisses Any Pfizer Vaccine ‘Envy’ Amid Buoyant Q2 Results

Growth Buoyant Despite Vaccine Complications

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.